MyAfroDNA, an African-centric Biobank Aims to Diversify Translational and Genomics Research

MyAfroDNA is a limited liability company that provides a solution to the significant lack of African representation in translational and genomics research. The African-centric biobank offers access to ethically sourced African biospecimens across several therapeutic areas for researchers interested in leveraging from such African bioresources to diversify and advance their research efforts. The company which has just begun its operation in Southern Nigeria has already struck partnerships with over 300 health facilities to aid the collection of biospecimens in diseases across major therapeutic areas.

Based on the biobank’s wide reach of access to African biospecimens from various diseases, they are capable of recruiting cohorts that will be of interest to potential collaborators and end-users. 

Click to read more.